Cf. Thomas et al., PNEUMOCYSTIS-CARINII CONTAINS A FUNCTIONAL CELL-DIVISION-CYCLE CDC2 HOMOLOG, American journal of respiratory cell and molecular biology, 18(3), 1998, pp. 297-306
Pneumocystis carinii causes life-threatening pneumonia in immunocompro
mised patients. The inability to culture P. carinii has hampered basic
investigations of the organism's life cycle, limiting the development
of new therapies directed against it. Recent investigations indicate
that P. carinii is a fungus phylogenetically related to other ascomyce
tes such as Schizosaccharomyces pombe. The cell cycles of S. pombe and
homologous fungi are carefully regulated by cell-division-cycle molec
ules (cdc), particularly cell-division-cycle 2 (Cdc2), a serine-threon
ine kinase with essential activity at the G(1) restriction point and f
or entry into mitosis. Antibodies to the otein-serine-threonine-alanin
e-isoleucine-arginine (PSTAIR) aminoacid sequence conserved in Cdc2 pr
oteins specifically precipitated, from P. carinii extracts, a molecule
with kinase activity consistent with a Cdc2-like protein. Cdc2 molecu
les exhibit differential activity throughout the life cycle of the org
anisms in which they occur. In accord with this, the P. carinii Cdc2 s
howed greater specific activity in P. carinii trophic forms (trophozoi
tes) than in spore-case forms (cysts). In addition, complete genomic a
nd complementary DNA (cDNA) sequences of P. carinii Cdc2 were cloned a
nd found to be most closely homologus to the corresponding sequences o
f other pathogenic fungi. The function of P. carinii cdc2 cDNA was fur
ther documented through its ability to complement the DNA of mutant st
rains of S. pombe with temperature-sensitive deficiencies in Cdc2 acti
vity. The P. carinii cdc2 cDNA restored normal Cdc2 function in these
mutant strains of S. pombe, and promoted fungal proliferation. These s
tudies represent the first molecular analysis of the cell-cycle-regula
tory machinery in P. carinii. Further understanding of P. carinii's li
fe cycle promises novel insights for preventing and treating the intra
ctable infection it causes in immunocompromised patients.